US2006073168A1PendingUtilityA1
Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
Individually held — no corporate assignee on recordPriority: Aug 11, 2004Filed: Aug 11, 2005Published: Apr 6, 2006
Est. expiryAug 11, 2024(expired)· nominal 20-yr term from priority
C12N 9/1029C12P 19/44A61P 31/04A61K 39/095A61K 39/00
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are recombinant DNA molecules that do not occur in nature encoding an O-acetyltransferase, vectors that direct expression of an O-acetyltransferase, recombinant host cells which express an O-acetyltransferase, methods for recombinant production of an O-acetyltransferase, methods for acetylating capsular polysaccharides, especially those of a Serogroup A Neisseria meningitidis using a recombinant O-acetyltransferase, and immunogenic compositions comprising the acetylated capsular polysaccharide.
Claims
exact text as granted — not AI-modified1 . A DNA molecule comprising a Serogroup A Neisseria meningitidis O-acetyltransferase coding sequence and transcriptional control sequences with which said O-acetyltransferase coding sequence is not associated in nature, said coding sequence and said transcriptional control sequences being operably linked.
2 . The DNA molecule of claim 1 , wherein said O-acetyltransferase consists of the amino acid sequence of SEQ ID NO:2.
3 . The DNA molecule of claim 2 , wherein said O-acetyltransferase coding sequence is as given in SEQ ID NO:1.
4 . The DNA molecule of claim 1 , further comprising a sequence encoding an affinity tag and fused in frame selected from the group consisting of a streptavidin tag, a flagellar antigen epitope tag, a polyhistidine tag, a glutathione-S-transferase tag or a calmodulin tag or a streptactin tag.
5 . The DNA molecule of claim 1 , further comprising vector sequences functional in a bacterial cell.
6 . The DNA molecule of claim 5 , wherein the vector sequences are functional in Escherichia coli.
7 . A bacterial host cell in which the DNA molecule of claim 1 is stably maintained.
8 . A method for recombinantly producing an O-acetyltransferase comprising the step of culturing the bacterial host cell of claim 6 under conditions such that the O-acetyltransferase is expressed.
9 . The method of claim 7 further comprising recovering the O-acetyltransferase.
10 . A method for acetylating Serogroup A capsular polysaccharide prepared from Neisseria meningitidis , said method comprising the step of contacting an isolated capsular polysaccharide with the O-acetyltransferase produced by the method of claim 9 .
11 . An improved immunogenic composition comprising an acetylated capsular polysaccharide of Neisseria meningitidis , wherein the improvement comprises acetylation of the capsular polysaccharide according to the method of claim 10.Join the waitlist — get patent alerts
Track US2006073168A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.